EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Pharmacokinetics and Safety with Bioequivalence of Isosorbide Mononitrate Sustained-Release Tablets in Chinese Healthy Volunteers: Bioequivalence Study

Binbin Wu, Wei Wang, Qikun Zhang, Guigui Yu, Jingjing Lin, Ting Zhang, Luxi Ye, Keli Wang, Wanggang Zhang iD, Xinyi Wu iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s508202 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Binbin Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Zhejiang Hospital, Hangzhou, 310030, People's Republic of China. Hauptthemen laut MEDLINE: Isosorbide Dinitrate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Isosorbide DinitrateAdultFemaleHumansMaleYoung AdultAdministration, OralChinaCross-Over StudiesDelayed-Action PreparationsHealthy VolunteersTabletsTherapeutic EquivalencyEast Asian People

Stichwörter der Autor:innen

Chinese healthy volunteersbioequivalenceisosorbide mononitratepharmacokineticssafety

Substanzen

Delayed-Action PreparationsIsosorbide Dinitrateisosorbide-5-mononitrateTablets

Autor:innen und Institutionen

  • Department of Nephrology, Zhejiang Hospital, Hangzhou, 310030, People's Republic of China.
  • Department of Emergency, Pingyang Hospital of Wenzhou Medical University, Wenzhou, 325400, People's Republic of China.
  • School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, 310053, People's Republic of China.
  • Nanjing Jiening Pharmaceutical Technology Co., Ltd, Nanjing, 211112, People's Republic of China.
  • Phase I Clinical Trial Center, Zhejiang Hospital, Hangzhou, 310030, People's Republic of China.

ORCID-Profile: Wanggang Zhang, Xinyi Wu

Zitieren

APA

Wu, B., Wang, W., Zhang, Q., Yu, G., Lin, J., Zhang, T., Ye, L., Wang, K., Zhang, W., & Wu, X. (2025). Pharmacokinetics and Safety with Bioequivalence of Isosorbide Mononitrate Sustained-Release Tablets in Chinese Healthy Volunteers: Bioequivalence Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s508202

Vancouver

Wu B, Wang W, Zhang Q, Yu G, Lin J, Zhang T, et al. Pharmacokinetics and Safety with Bioequivalence of Isosorbide Mononitrate Sustained-Release Tablets in Chinese Healthy Volunteers: Bioequivalence Study. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s508202

BibTeX
@article{Wu2025,
  author = {Wu, Binbin and Wang, Wei and Zhang, Qikun and Yu, Guigui and Lin, Jingjing and Zhang, Ting and Ye, Luxi and Wang, Keli and Zhang, Wanggang and Wu, Xinyi},
  title = {Pharmacokinetics and Safety with Bioequivalence of Isosorbide Mononitrate Sustained-Release Tablets in Chinese Healthy Volunteers: Bioequivalence Study},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s508202}
}
Kostenlos starten →